SIGLEC1 and lymphoma: Interestingly, in CD169-/- mouse model, lymphoma-derived apoptotic bodies are taken up by DCs to enhance CD8 + T cells antitumor response, presumably due to the absence of immunosuppressive CD169 + macrophages [242].